Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 8—August 2026
Dispatch
Detection of Congenital Syphilis via Digital PCR and Next-Generation Sequencing, Colombia
Table
Newborn clinical test results for detection of congenital syphilis via digital PCR and next-generation sequencing, Colombia*
| Parameter | Patient values | CS range (reference) |
|---|---|---|
| Blood | ||
| Leukocytes, cells/µL | 11,090 | >35,000 (3,4) |
| Platelets, cells/µL | 137,000 | <150,000 (3,4) |
| AST, U/L | 26 | >34.46 (3,4) |
| ALT, U/L | <7 | >12.35 (3,4) |
| Total bilirubin, µmol/L | 85.33 | NA† |
| Direct bilirubin, µmol/L |
13.33 |
>20% of total bilirubin (3,4) |
| Cerebrospinal fluid | ||
| Leukocytes, cells/mm3 | 3 | <15 (3,5) |
| Erythrocytes, cells/mm3 | 5 (100% fresh) | NA |
| Proteins | 92.2 | Premature newborn, <170 (3,5); full-term newborn <30 days of age, <120 (3,5) |
| Glucose, mg/dL | 58 | NA |
| VDRL test | Nonreactive | Reactive |
*ALT, alanine transaminase; AST, aspartate aminotransferase; CS, congenital syphilis; NA, not applicable; VDRL, venereal disease research laboratory. †No parameter suggestive of CS has been established.
References
- World Health Organization. WHO guidelines for the treatment of Treponema pallidum (syphilis). Geneva; The Organization: 2016.
- Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70:1–187. DOIPubMedGoogle Scholar
- Ministry of Health and Social Protection. Evidence-based clinical practice guideline (CPG) for the comprehensive care of gestational and congenital syphilis [in Spanish]. Bogata: The Ministry; 2014.
- National Institute of Health. Public health surveillance protocol for gestational and congenital syphilis [in Spanish]. Bogata: The Institute; 2015.
- Centers for Disease Control and Prevention. Congenital syphilis (CS) case investigation and report form, 2013 [cited 2025 Oct 27]. https://stacks.cdc.gov/view/61366
- Papp JR, Park IU, Fakile Y, Pereira L, Pillay A, Bolan GA. CDC laboratory recommendations for syphilis testing, United States, 2024. MMWR Recomm Rep. 2024;73:1–32. DOIPubMedGoogle Scholar
- Palmer HM, Higgins SP, Herring AJ, Kingston MA. Use of PCR in the diagnosis of early syphilis in the United Kingdom. Sex Transm Infect. 2003;79:479–83. DOIPubMedGoogle Scholar
- Sancha Dominguez L, Cotos Suárez A, Sánchez Ledesma M, Muñoz Bellido JL. Present and future applications of digital PCR in infectious diseases diagnosis. Diagnostics (Basel). 2024;14:931. DOIPubMedGoogle Scholar
- Li G, Sun H, Ye Y, Chen L, Zhang W, Yu S, et al. Clinical utility of nanopore-targeted sequencing for diagnosing and treating pulmonary infectious diseases from bronchoalveolar lavage fluid. Front Cell Infect Microbiol. 2025;15:
1469440 . DOIPubMedGoogle Scholar - Edmondson DG, Hu B, Norris SJ. Long-term in vitro culture of the syphilis spirochete Treponema pallidum subsp. pallidum. MBio. 2018;9:e01153–18. DOIPubMedGoogle Scholar
- Wicher K, Wicher V. Median infective dose of Treponema pallidum determined in a highly susceptible guinea pig strain. Infect Immun. 1991;59:453–6. DOIPubMedGoogle Scholar
- Arnold SR, Ford-Jones EL. Congenital syphilis: a guide to diagnosis and management. Paediatr Child Health. 2000;5:463–9. DOIPubMedGoogle Scholar
Page created: June 23, 2026
Page updated: July 17, 2026
Page reviewed: July 17, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.